BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pipili C, Cholongitas E. Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation. World J Hepatol 2014; 6(5): 315-325 [PMID: 24868325 DOI: 10.4254/wjh.v6.i5.315]
URL: https://www.wjgnet.com/1948-5182/full/v6/i5/315.htm
Number Citing Articles
1
E. Cholongitas, I. Goulis, N. Antoniadis, I. Fouzas, G. Imvrios, D. Giakoustidis, O. Giouleme, V. Papanikolaou, E. Akriviadis, T. Vasiliadis. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantationTransplant Infectious Disease 2016; 18(5): 667 doi: 10.1111/tid.12575
2
Evangelos Cholongitas, Konstantinos Tziomalos, Chrysoula Pipili. Management of patients with hepatitis B in special populationsWorld Journal of Gastroenterology 2015; 21(6): 1738-1748 doi: 10.3748/wjg.v21.i6.1738
3
Giuseppe Coppolino, Mariadelina Simeoni, Chiara Summaria, Maria Concetta Postorino, Laura Rivoli, Alessio Strazzulla, Carlo Torti, Giorgio Fuiano. The case of chronic hepatitis B treatment with tenofovir: an update for nephrologistsJournal of Nephrology 2015; 28(4): 393 doi: 10.1007/s40620-015-0214-0
4
Arno Kornberg. Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulationWorld Journal of Hepatology 2015; 7(11): 1494-1508 doi: 10.4254/wjh.v7.i11.1494
5
Raul Carlos Wahle, Renata de Mello Perez, Christini Takemi Emori, Silvia Naomi de Oliveira Uehara, Patrícia da Silva Fucuta, Cristina Melo Rocha, Ana Cristina de Castro Amaral Feldner, Ivonete Sandra de Souza e Silva, Roberto José Carvalho-Filho, Antônio Eduardo Benedito Silva, Maria Lucia Gomes Ferraz. Does hepatitis B virus coinfection have any impact on treatment outcome in hepatitis C patients on hemodialysis?Annals of Hepatology 2015; 14(3): 317 doi: 10.1016/S1665-2681(19)31270-0
6
Ezequiel Ridruejo. Antiviral treatment for chronic hepatitis B in renal transplant patientsWorld Journal of Hepatology 2015; 7(2): 189-203 doi: 10.4254/wjh.v7.i2.189
7
Chrysoula Pipili, Evangelos Cholongitas. Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?World Journal of Hepatology 2015; 7(12): 1606-1616 doi: 10.4254/wjh.v7.i12.1606
8
E. Durante-Mangoni, M. Vitrone, A. Parrella, R. Andini, D. Iossa, E. Ragone, E. Falco, C. Maiello, R. Utili, R. Zampino. Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipientsTransplant Infectious Disease 2016; 18(3): 319 doi: 10.1111/tid.12525
9
Chrysoula Pipili, Evangelos Cholongitas. Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipientsWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 105-110 doi: 10.4292/wjgpt.v6.i4.105